Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
According to APO Research, The global Bacteriophage market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and Pherecydes Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Bacteriophage, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Bacteriophage, also provides the revenue of main regions and countries. Of the upcoming market potential for Bacteriophage, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bacteriophage revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Bacteriophage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Bacteriophage revenue, projected growth trends, production technology, application and end-user industry.
Bacteriophage Segment by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Bacteriophage Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacteriophage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacteriophage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacteriophage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Bacteriophage in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Bacteriophage company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacteriophage revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
- Market Overview
- Product Definition
- Bacteriophage Market by Type
- Global Bacteriophage Market Size by Type, 2020 VS 2024 VS 2031
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
- Others
- Bacteriophage Market by Application
- Global Bacteriophage Market Size by Application, 2020 VS 2024 VS 2031
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Human Health
- Others
- Assumptions and Limitations
- Study Goals and Objectives
- Bacteriophage Market Dynamics
- Bacteriophage Industry Trends
- Bacteriophage Industry Drivers
- Bacteriophage Industry Opportunities and Challenges
- Bacteriophage Industry Restraints
- Global Growth Perspective
- Global Bacteriophage Market Perspective (2020-2031)
- Global Bacteriophage Growth Trends by Region
- Global Bacteriophage Market Size by Region: 2020 VS 2024 VS 2031
- Global Bacteriophage Market Size by Region (2020-2025)
- Global Bacteriophage Market Size by Region (2026-2031)
- Competitive Landscape by Players
- Global Bacteriophage Revenue by Players
- Global Bacteriophage Revenue by Players (2020-2025)
- Global Bacteriophage Revenue Market Share by Players (2020-2025)
- Global Bacteriophage Players Revenue Share Top 10 and Top 5 in 2024
- Global Bacteriophage Key Players Ranking, 2023 VS 2024 VS 2025
- Global Bacteriophage Key Players Headquarters & Area Served
- Global Bacteriophage Players, Product Type & Application
- Global Bacteriophage Players Establishment Date
- Market Competitive Analysis
- Global Bacteriophage Market CR5 and HHI
- 2024 Bacteriophage Tier 1, Tier 2, and Tier 3
- Global Bacteriophage Revenue by Players
- Bacteriophage Market Size by Type
- Global Bacteriophage Revenue by Type (2020 VS 2024 VS 2031)
- Global Bacteriophage Revenue by Type (2020-2031)
- Global Bacteriophage Revenue Market Share by Type (2020-2031)
- Bacteriophage Market Size by Application
- Global Bacteriophage Revenue by Application (2020 VS 2024 VS 2031)
- Global Bacteriophage Revenue by Application (2020-2031)
- Global Bacteriophage Revenue Market Share by Application (2020-2031)
- Company Profiles
- NPO Microgen
- NPO Microgen Comapny Information
- NPO Microgen Business Overview
- NPO Microgen Bacteriophage Revenue and Gross Margin (2020-2025)
- NPO Microgen Bacteriophage Product Portfolio
- NPO Microgen Recent Developments
- Proteon Pharmaceuticals
- Proteon Pharmaceuticals Comapny Information
- Proteon Pharmaceuticals Business Overview
- Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin (2020-2025)
- Proteon Pharmaceuticals Bacteriophage Product Portfolio
- Proteon Pharmaceuticals Recent Developments
- Phagelux
- Phagelux Comapny Information
- Phagelux Business Overview
- Phagelux Bacteriophage Revenue and Gross Margin (2020-2025)
- Phagelux Bacteriophage Product Portfolio
- Phagelux Recent Developments
- Intralytix
- Intralytix Comapny Information
- Intralytix Business Overview
- Intralytix Bacteriophage Revenue and Gross Margin (2020-2025)
- Intralytix Bacteriophage Product Portfolio
- Intralytix Recent Developments
- Micreos
- Micreos Comapny Information
- Micreos Business Overview
- Micreos Bacteriophage Revenue and Gross Margin (2020-2025)
- Micreos Bacteriophage Product Portfolio
- Micreos Recent Developments
- Eliava BioPreparations
- Eliava BioPreparations Comapny Information
- Eliava BioPreparations Business Overview
- Eliava BioPreparations Bacteriophage Revenue and Gross Margin (2020-2025)
- Eliava BioPreparations Bacteriophage Product Portfolio
- Eliava BioPreparations Recent Developments
- Locus Biosciences,Inc
- Locus Biosciences,Inc Comapny Information
- Locus Biosciences,Inc Business Overview
- Locus Biosciences,Inc Bacteriophage Revenue and Gross Margin (2020-2025)
- Locus Biosciences,Inc Bacteriophage Product Portfolio
- Locus Biosciences,Inc Recent Developments
- Pharmex Group,LLC
- Pharmex Group,LLC Comapny Information
- Pharmex Group,LLC Business Overview
- Pharmex Group,LLC Bacteriophage Revenue and Gross Margin (2020-2025)
- Pharmex Group,LLC Bacteriophage Product Portfolio
- Pharmex Group,LLC Recent Developments
- Pherecydes Pharma
- Pherecydes Pharma Comapny Information
- Pherecydes Pharma Business Overview
- Pherecydes Pharma Bacteriophage Revenue and Gross Margin (2020-2025)
- Pherecydes Pharma Bacteriophage Product Portfolio
- Pherecydes Pharma Recent Developments
- APS Biocontrol Ltd. (APS)
- APS Biocontrol Ltd. (APS) Comapny Information
- APS Biocontrol Ltd. (APS) Business Overview
- APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin (2020-2025)
- APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio
- APS Biocontrol Ltd. (APS) Recent Developments
- Qingdao Phagepharm Bio-tech
- Qingdao Phagepharm Bio-tech Comapny Information
- Qingdao Phagepharm Bio-tech Business Overview
- Qingdao Phagepharm Bio-tech Bacteriophage Revenue and Gross Margin (2020-2025)
- Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio
- Qingdao Phagepharm Bio-tech Recent Developments
- Fixed-Phage Limited
- Fixed-Phage Limited Comapny Information
- Fixed-Phage Limited Business Overview
- Fixed-Phage Limited Bacteriophage Revenue and Gross Margin (2020-2025)
- Fixed-Phage Limited Bacteriophage Product Portfolio
- Fixed-Phage Limited Recent Developments
- Zeptometrix
- Zeptometrix Comapny Information
- Zeptometrix Business Overview
- Zeptometrix Bacteriophage Revenue and Gross Margin (2020-2025)
- Zeptometrix Bacteriophage Product Portfolio
- Zeptometrix Recent Developments
- Phage International, Inc.
- Phage International, Inc. Comapny Information
- Phage International, Inc. Business Overview
- Phage International, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
- Phage International, Inc. Bacteriophage Product Portfolio
- Phage International, Inc. Recent Developments
- MicroMir
- MicroMir Comapny Information
- MicroMir Business Overview
- MicroMir Bacteriophage Revenue and Gross Margin (2020-2025)
- MicroMir Bacteriophage Product Portfolio
- MicroMir Recent Developments
- iNtODEWORLD, Inc.
- iNtODEWORLD, Inc. Comapny Information
- iNtODEWORLD, Inc. Business Overview
- iNtODEWORLD, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
- iNtODEWORLD, Inc. Bacteriophage Product Portfolio
- iNtODEWORLD, Inc. Recent Developments
- NEXTBIOTICS
- NEXTBIOTICS Comapny Information
- NEXTBIOTICS Business Overview
- NEXTBIOTICS Bacteriophage Revenue and Gross Margin (2020-2025)
- NEXTBIOTICS Bacteriophage Product Portfolio
- NEXTBIOTICS Recent Developments
- Armata Pharmaceuticals, Inc.
- Armata Pharmaceuticals, Inc. Comapny Information
- Armata Pharmaceuticals, Inc. Business Overview
- Armata Pharmaceuticals, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
- Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio
- Armata Pharmaceuticals, Inc. Recent Developments
- Innophage
- Innophage Comapny Information
- Innophage Business Overview
- Innophage Bacteriophage Revenue and Gross Margin (2020-2025)
- Innophage Bacteriophage Product Portfolio
- Innophage Recent Developments
- Adaptive Phage Therapeutics
- Adaptive Phage Therapeutics Comapny Information
- Adaptive Phage Therapeutics Business Overview
- Adaptive Phage Therapeutics Bacteriophage Revenue and Gross Margin (2020-2025)
- Adaptive Phage Therapeutics Bacteriophage Product Portfolio
- Adaptive Phage Therapeutics Recent Developments
- TechnoPhage
- TechnoPhage Comapny Information
- TechnoPhage Business Overview
- TechnoPhage Bacteriophage Revenue and Gross Margin (2020-2025)
- TechnoPhage Bacteriophage Product Portfolio
- TechnoPhage Recent Developments
- NPO Microgen
- North America
- North America Bacteriophage Revenue (2020-2031)
- North America Bacteriophage Revenue by Type (2020-2031)
- North America Bacteriophage Revenue by Type (2020-2025)
- North America Bacteriophage Revenue by Type (2026-2031)
- North America Bacteriophage Revenue Share by Type (2020-2031)
- North America Bacteriophage Revenue by Application (2020-2031)
- North America Bacteriophage Revenue by Application (2020-2025)
- North America Bacteriophage Revenue by Application (2026-2031)
- North America Bacteriophage Revenue Share by Application (2020-2031)
- North America Bacteriophage Revenue by Country
- North America Bacteriophage Revenue by Country (2020 VS 2024 VS 2031)
- North America Bacteriophage Revenue by Country (2020-2025)
- North America Bacteriophage Revenue by Country (2026-2031)
- United States
- Canada
- Mexico
- Europe
- Europe Bacteriophage Revenue (2020-2031)
- Europe Bacteriophage Revenue by Type (2020-2031)
- Europe Bacteriophage Revenue by Type (2020-2025)
- Europe Bacteriophage Revenue by Type (2026-2031)
- Europe Bacteriophage Revenue Share by Type (2020-2031)
- Europe Bacteriophage Revenue by Application (2020-2031)
- Europe Bacteriophage Revenue by Application (2020-2025)
- Europe Bacteriophage Revenue by Application (2026-2031)
- Europe Bacteriophage Revenue Share by Application (2020-2031)
- Europe Bacteriophage Revenue by Country
- Europe Bacteriophage Revenue by Country (2020 VS 2024 VS 2031)
- Europe Bacteriophage Revenue by Country (2020-2025)
- Europe Bacteriophage Revenue by Country (2026-2031)
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- China
- China Bacteriophage Revenue (2020-2031)
- China Bacteriophage Revenue by Type (2020-2031)
- China Bacteriophage Revenue by Type (2020-2025)
- China Bacteriophage Revenue by Type (2026-2031)
- China Bacteriophage Revenue Share by Type (2020-2031)
- China Bacteriophage Revenue by Application (2020-2031)
- China Bacteriophage Revenue by Application (2020-2025)
- China Bacteriophage Revenue by Application (2026-2031)
- China Bacteriophage Revenue Share by Application (2020-2031)
- Asia (Excluding China)
- Asia Bacteriophage Revenue (2020-2031)
- Asia Bacteriophage Revenue by Type (2020-2031)
- Asia Bacteriophage Revenue by Type (2020-2025)
- Asia Bacteriophage Revenue by Type (2026-2031)
- Asia Bacteriophage Revenue Share by Type (2020-2031)
- Asia Bacteriophage Revenue by Application (2020-2031)
- Asia Bacteriophage Revenue by Application (2020-2025)
- Asia Bacteriophage Revenue by Application (2026-2031)
- Asia Bacteriophage Revenue Share by Application (2020-2031)
- Asia Bacteriophage Revenue by Country
- Asia Bacteriophage Revenue by Country (2020 VS 2024 VS 2031)
- Asia Bacteriophage Revenue by Country (2020-2025)
- Asia Bacteriophage Revenue by Country (2026-2031)
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America, Middle East and Africa
- SAMEA Bacteriophage Revenue (2020-2031)
- SAMEA Bacteriophage Revenue by Type (2020-2031)
- SAMEA Bacteriophage Revenue by Type (2020-2025)
- SAMEA Bacteriophage Revenue by Type (2026-2031)
- SAMEA Bacteriophage Revenue Share by Type (2020-2031)
- SAMEA Bacteriophage Revenue by Application (2020-2031)
- SAMEA Bacteriophage Revenue by Application (2020-2025)
- SAMEA Bacteriophage Revenue by Application (2026-2031)
- SAMEA Bacteriophage Revenue Share by Application (2020-2031)
- SAMEA Bacteriophage Revenue by Country
- SAMEA Bacteriophage Revenue by Country (2020 VS 2024 VS 2031)
- SAMEA Bacteriophage Revenue by Country (2020-2025)
- SAMEA Bacteriophage Revenue by Country (2026-2031)
- Brazil
- Argentina
- Chile
- Colombia
- Peru
- Saudi Arabia
- Israel
- UAE
- Turkey
- Iran
- Egypt
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
- Disclaimer
List of Tables
| Table 1 | :Global Bacteriophage Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031 |
| Table 2 | :DsDNA Bacteriophage Major Player |
| Table 3 | :SsDNA Bacteriophage Major Player |
| Table 4 | :SsRNA Bacteriophage Major Player |
| Table 5 | :Others Major Player |
| Table 6 | :Global Bacteriophage Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031 |
| Table 7 | :Animal Health Major Player |
| Table 8 | :Aquaculture Major Player |
| Table 9 | :Agriculture Major Player |
| Table 10 | :Food Industry Major Player |
| Table 11 | :Human Health Major Player |
| Table 12 | :Others Major Player |
| Table 13 | :Bacteriophage Industry Trends |
| Table 14 | :Bacteriophage Industry Drivers |
| Table 15 | :Bacteriophage Industry Opportunities and Challenges |
| Table 16 | :Bacteriophage Industry Restraints |
| Table 17 | :Global Bacteriophage Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031 |
| Table 18 | :Global Bacteriophage Market Size by Region (2020-2025) & (US$ Million) |
| Table 19 | :Global Bacteriophage Market Share by Region (2020-2025) |
| Table 20 | :Global Bacteriophage Market Size by Region (2026-2031) & (US$ Million) |
| Table 21 | :Global Bacteriophage Market Share by Region (2026-2031) |
| Table 22 | :Global Bacteriophage Revenue by Players (US$ Million) & (2020-2025) |
| Table 23 | :Global Bacteriophage Revenue Market Share by Players (2020-2025) |
| Table 24 | :Global Bacteriophage Key Players Ranking, 2023 VS 2024 VS 2025 |
| Table 25 | :Global Bacteriophage Key Players Headquarters & Area Served |
| Table 26 | :Global Bacteriophage Players, Product Type & Application |
| Table 27 | :Global Bacteriophage Players Establishment Date |
| Table 28 | :Global Players Market Concentration Ratio (CR5 and HHI) |
| Table 29 | :Global Bacteriophage by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024) |
| Table 30 | :Global Bacteriophage Revenue by Type 2020 VS 2024 VS 2031 (US$ Million) |
| Table 31 | :Global Bacteriophage Revenue by Type (2020-2025) & (US$ Million) |
| Table 32 | :Global Bacteriophage Revenue by Type (2026-2031) & (US$ Million) |
| Table 33 | :Global Bacteriophage Revenue Market Share by Type (2020-2025) & (US$ Million) |
| Table 34 | :Global Bacteriophage Revenue Market Share by Type (2026-2031) & (US$ Million) |
| Table 35 | :Global Bacteriophage Revenue by Application 2020 VS 2024 VS 2031 (US$ Million) |
| Table 36 | :Global Bacteriophage Revenue by Application (2020-2025) & (US$ Million) |
| Table 37 | :Global Bacteriophage Revenue by Application (2026-2031) & (US$ Million) |
| Table 38 | :Global Bacteriophage Revenue Market Share by Application (2020-2025) & (US$ Million) |
| Table 39 | :Global Bacteriophage Revenue Market Share by Application (2026-2031) & (US$ Million) |
| Table 40 | :NPO Microgen Company Information |
| Table 41 | :NPO Microgen Business Overview |
| Table 42 | :NPO Microgen Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 43 | :NPO Microgen Bacteriophage Product Portfolio |
| Table 44 | :NPO Microgen Recent Development |
| Table 45 | :Proteon Pharmaceuticals Company Information |
| Table 46 | :Proteon Pharmaceuticals Business Overview |
| Table 47 | :Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 48 | :Proteon Pharmaceuticals Bacteriophage Product Portfolio |
| Table 49 | :Proteon Pharmaceuticals Recent Development |
| Table 50 | :Phagelux Company Information |
| Table 51 | :Phagelux Business Overview |
| Table 52 | :Phagelux Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 53 | :Phagelux Bacteriophage Product Portfolio |
| Table 54 | :Phagelux Recent Development |
| Table 55 | :Intralytix Company Information |
| Table 56 | :Intralytix Business Overview |
| Table 57 | :Intralytix Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 58 | :Intralytix Bacteriophage Product Portfolio |
| Table 59 | :Intralytix Recent Development |
| Table 60 | :Micreos Company Information |
| Table 61 | :Micreos Business Overview |
| Table 62 | :Micreos Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 63 | :Micreos Bacteriophage Product Portfolio |
| Table 64 | :Micreos Recent Development |
| Table 65 | :Eliava BioPreparations Company Information |
| Table 66 | :Eliava BioPreparations Business Overview |
| Table 67 | :Eliava BioPreparations Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 68 | :Eliava BioPreparations Bacteriophage Product Portfolio |
| Table 69 | :Eliava BioPreparations Recent Development |
| Table 70 | :Locus Biosciences,Inc Company Information |
| Table 71 | :Locus Biosciences,Inc Business Overview |
| Table 72 | :Locus Biosciences,Inc Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 73 | :Locus Biosciences,Inc Bacteriophage Product Portfolio |
| Table 74 | :Locus Biosciences,Inc Recent Development |
| Table 75 | :Pharmex Group,LLC Company Information |
| Table 76 | :Pharmex Group,LLC Business Overview |
| Table 77 | :Pharmex Group,LLC Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 78 | :Pharmex Group,LLC Bacteriophage Product Portfolio |
| Table 79 | :Pharmex Group,LLC Recent Development |
| Table 80 | :Pherecydes Pharma Company Information |
| Table 81 | :Pherecydes Pharma Business Overview |
| Table 82 | :Pherecydes Pharma Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 83 | :Pherecydes Pharma Bacteriophage Product Portfolio |
| Table 84 | :Pherecydes Pharma Recent Development |
| Table 85 | :APS Biocontrol Ltd. (APS) Company Information |
| Table 86 | :APS Biocontrol Ltd. (APS) Business Overview |
| Table 87 | :APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 88 | :APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio |
| Table 89 | :APS Biocontrol Ltd. (APS) Recent Development |
| Table 90 | :Qingdao Phagepharm Bio-tech Company Information |
| Table 91 | :Qingdao Phagepharm Bio-tech Business Overview |
| Table 92 | :Qingdao Phagepharm Bio-tech Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 93 | :Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio |
| Table 94 | :Qingdao Phagepharm Bio-tech Recent Development |
| Table 95 | :Fixed-Phage Limited Company Information |
| Table 96 | :Fixed-Phage Limited Business Overview |
| Table 97 | :Fixed-Phage Limited Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 98 | :Fixed-Phage Limited Bacteriophage Product Portfolio |
| Table 99 | :Fixed-Phage Limited Recent Development |
| Table 100 | :Zeptometrix Company Information |
| Table 101 | :Zeptometrix Business Overview |
| Table 102 | :Zeptometrix Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 103 | :Zeptometrix Bacteriophage Product Portfolio |
| Table 104 | :Zeptometrix Recent Development |
| Table 105 | :Phage International, Inc. Company Information |
| Table 106 | :Phage International, Inc. Business Overview |
| Table 107 | :Phage International, Inc. Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 108 | :Phage International, Inc. Bacteriophage Product Portfolio |
| Table 109 | :Phage International, Inc. Recent Development |
| Table 110 | :MicroMir Company Information |
| Table 111 | :MicroMir Business Overview |
| Table 112 | :MicroMir Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 113 | :MicroMir Bacteriophage Product Portfolio |
| Table 114 | :MicroMir Recent Development |
| Table 115 | :iNtODEWORLD, Inc. Company Information |
| Table 116 | :iNtODEWORLD, Inc. Business Overview |
| Table 117 | :iNtODEWORLD, Inc. Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 118 | :iNtODEWORLD, Inc. Bacteriophage Product Portfolio |
| Table 119 | :iNtODEWORLD, Inc. Recent Development |
| Table 120 | :NEXTBIOTICS Company Information |
| Table 121 | :NEXTBIOTICS Business Overview |
| Table 122 | :NEXTBIOTICS Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 123 | :NEXTBIOTICS Bacteriophage Product Portfolio |
| Table 124 | :NEXTBIOTICS Recent Development |
| Table 125 | :Armata Pharmaceuticals, Inc. Company Information |
| Table 126 | :Armata Pharmaceuticals, Inc. Business Overview |
| Table 127 | :Armata Pharmaceuticals, Inc. Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 128 | :Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio |
| Table 129 | :Armata Pharmaceuticals, Inc. Recent Development |
| Table 130 | :Innophage Company Information |
| Table 131 | :Innophage Business Overview |
| Table 132 | :Innophage Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 133 | :Innophage Bacteriophage Product Portfolio |
| Table 134 | :Innophage Recent Development |
| Table 135 | :Adaptive Phage Therapeutics Company Information |
| Table 136 | :Adaptive Phage Therapeutics Business Overview |
| Table 137 | :Adaptive Phage Therapeutics Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 138 | :Adaptive Phage Therapeutics Bacteriophage Product Portfolio |
| Table 139 | :Adaptive Phage Therapeutics Recent Development |
| Table 140 | :TechnoPhage Company Information |
| Table 141 | :TechnoPhage Business Overview |
| Table 142 | :TechnoPhage Bacteriophage Sales (L), Revenue (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
| Table 143 | :TechnoPhage Bacteriophage Product Portfolio |
| Table 144 | :TechnoPhage Recent Development |
| Table 145 | :North America Bacteriophage Revenue by Type (2020-2025) & (US$ Million) |
| Table 146 | :North America Bacteriophage Revenue by Application (2020-2025) & (US$ Million) |
| Table 147 | :North America Bacteriophage Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 148 | :North America Bacteriophage Revenue by Country (2020-2025) & (US$ Million) |
| Table 149 | :North America Bacteriophage Revenue by Country (2026-2031) & (US$ Million) |
| Table 150 | :Europe Bacteriophage Revenue by Type (2020-2025) & (US$ Million) |
| Table 151 | :Europe Bacteriophage Revenue by Application (2020-2025) & (US$ Million) |
| Table 152 | :Europe Bacteriophage Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 153 | :Europe Bacteriophage Revenue by Country (2020-2025) & (US$ Million) |
| Table 154 | :Europe Bacteriophage Revenue by Country (2026-2031) & (US$ Million) |
| Table 155 | :China Bacteriophage Revenue by Type (2020-2025) & (US$ Million) |
| Table 156 | :China Bacteriophage Revenue by Application (2020-2025) & (US$ Million) |
| Table 157 | :Asia Bacteriophage Revenue by Type (2020-2025) & (US$ Million) |
| Table 158 | :Asia Bacteriophage Revenue by Application (2020-2025) & (US$ Million) |
| Table 159 | :Asia Bacteriophage Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 160 | :Asia Bacteriophage Revenue by Country (2020-2025) & (US$ Million) |
| Table 161 | :Asia Bacteriophage Revenue by Country (2026-2031) & (US$ Million) |
| Table 162 | :SAMEA Bacteriophage Revenue by Type (2020-2025) & (US$ Million) |
| Table 163 | :SAMEA Bacteriophage Revenue by Application (2020-2025) & (US$ Million) |
| Table 164 | :SAMEA Bacteriophage Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 165 | :SAMEA Bacteriophage Revenue by Country (2020-2025) & (US$ Million) |
| Table 166 | :SAMEA Bacteriophage Revenue by Country (2026-2031) & (US$ Million) |
| Table 167 | :Research Programs/Design for This Report |
| Table 168 | :Authors List of This Report |
| Table 169 | :Secondary Sources |
| Table 170 | :Primary Sources |
List of Figures
| Figure 1 | :Bacteriophage Image |
| Figure 2 | :Global Bacteriophage Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031 |
| Figure 3 | :Global Bacteriophage Market Size Share 2020 VS 2024 VS 2031 |
| Figure 4 | :DsDNA Bacteriophage Image |
| Figure 5 | :SsDNA Bacteriophage Image |
| Figure 6 | :SsRNA Bacteriophage Image |
| Figure 7 | :Others Image |
| Figure 8 | :Global Bacteriophage Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031 |
| Figure 9 | :Global Bacteriophage Market Size Share 2020 VS 2024 VS 2031 |
| Figure 10 | :Animal Health Image |
| Figure 11 | :Aquaculture Image |
| Figure 12 | :Agriculture Image |
| Figure 13 | :Food Industry Image |
| Figure 14 | :Human Health Image |
| Figure 15 | :Others Image |
| Figure 16 | :Global Bacteriophage Market Size (US$ Million) & (2020-2031) |
| Figure 17 | :Global Bacteriophage Market Size, (US$ Million), 2020 VS 2024 VS 2031 |
| Figure 18 | :Global Bacteriophage Market Share by Region: 2020 VS 2024 VS 2031 |
| Figure 19 | :Global Bacteriophage Players Revenue Share Top 10 and Top 5 in 2024 |
| Figure 20 | :Players Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024 |
| Figure 21 | :Global Bacteriophage Revenue by Type (2020 VS 2024 VS 2031) & (US$ Million) |
| Figure 22 | :Global Bacteriophage Revenue Market Share 2020 VS 2024 VS 2031 |
| Figure 23 | :Global Bacteriophage Revenue Market Share by Type (2020-2031) |
| Figure 24 | :Global Bacteriophage Revenue by Application (2020 VS 2024 VS 2031) & (US$ Million) |
| Figure 25 | :Global Bacteriophage Revenue Market Share by Application (2020 VS 2024 VS 2031) |
| Figure 26 | :Global Bacteriophage Revenue Market Share by Application (2020-2031) |
| Figure 27 | :North America Bacteriophage Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 28 | :North America Bacteriophage Revenue by Type (2026-2031) & (US$ Million) |
| Figure 29 | :North America Bacteriophage Revenue Share by Type (2020-2031) |
| Figure 30 | :North America Bacteriophage Revenue by Application (2026-2031) & (US$ Million) |
| Figure 31 | :North America Bacteriophage Revenue Share by Application (2020-2031) |
| Figure 32 | :North America Bacteriophage Revenue Share by Country (2020-2031) |
| Figure 33 | :United States Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 34 | :Canada Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 35 | :Mexico Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 36 | :Europe Bacteriophage Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 37 | :Europe Bacteriophage Revenue by Type (2026-2031) & (US$ Million) |
| Figure 38 | :Europe Bacteriophage Revenue Share by Type (2020-2031) |
| Figure 39 | :Europe Bacteriophage Revenue by Application (2026-2031) & (US$ Million) |
| Figure 40 | :Europe Bacteriophage Revenue Share by Application (2020-2031) |
| Figure 41 | :Europe Bacteriophage Revenue Share by Country (2020-2031) |
| Figure 42 | :Germany Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 43 | :France Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 44 | :U.K. Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 45 | :Italy Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 46 | :Spain Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 47 | :Russia Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 48 | :Netherlands Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 49 | :Nordic Countries Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 50 | :China Bacteriophage Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 51 | :China Bacteriophage Revenue by Type (2026-2031) & (US$ Million) |
| Figure 52 | :China Bacteriophage Revenue Share by Type (2020-2031) |
| Figure 53 | :China Bacteriophage Revenue by Application (2026-2031) & (US$ Million) |
| Figure 54 | :China Bacteriophage Revenue Share by Application (2020-2031) |
| Figure 55 | :Asia Bacteriophage Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 56 | :Asia Bacteriophage Revenue by Type (2026-2031) & (US$ Million) |
| Figure 57 | :Asia Bacteriophage Revenue Share by Type (2020-2031) |
| Figure 58 | :Asia Bacteriophage Revenue by Application (2026-2031) & (US$ Million) |
| Figure 59 | :Asia Bacteriophage Revenue Share by Application (2020-2031) |
| Figure 60 | :Asia Bacteriophage Revenue Share by Country (2020-2031) |
| Figure 61 | :Japan Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 62 | :South Korea Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 63 | :India Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 64 | :Australia Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 65 | :Taiwan Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 66 | :Southeast Asia Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 67 | :SAMEA Bacteriophage Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 68 | :SAMEA Bacteriophage Revenue by Type (2026-2031) & (US$ Million) |
| Figure 69 | :SAMEA Bacteriophage Revenue Share by Type (2020-2031) |
| Figure 70 | :SAMEA Bacteriophage Revenue by Application (2026-2031) & (US$ Million) |
| Figure 71 | :SAMEA Bacteriophage Revenue Share by Application (2020-2031) |
| Figure 72 | :SAMEA Bacteriophage Revenue Share by Country (2020-2031) |
| Figure 73 | :Brazil Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 74 | :Argentina Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 75 | :Chile Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 76 | :Colombia Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 77 | :Peru Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 78 | :Saudi Arabia Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 79 | :Israel Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 80 | :UAE Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 81 | :Turkey Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 82 | :Iran Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 83 | :Egypt Bacteriophage Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 84 | :Years Considered |
| Figure 85 | :Research Process |
| Figure 86 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Agriculture
Global Bacteriophage Market Analysis and Forecast 2025-2031
Pages: 212
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.